2,3,4,5-Tetrahydroxy-6-oxohexanamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡喃
• 英文名称: 2,3,4,5-Tetrahydroxy-6-oxohexanamide
• 英文别名: 3,4,5,6-tetrahydroxyoxane-2-carboxamide
• 化学式: C₆H₁₁NO₆
• mdl: MFCD24392276
• 分子量: 193.15
• InChiKey: VOIFKEWOFUNPBN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -3
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.833
• 拓扑面积：
  133
• 氢给体数：
  5
• 氢受体数：
  6

文献信息

• VITAMIN COMPRISING PYROLOQUINOLINE QUINONE AND USE THEREOF
  申请人：RIKEN

  公开号：EP1588709A1

  公开（公告）日：2005-10-26

  It is an object of the present invention to clarify the biochemical role of pyrroloquinoline quinone (PQQ) in living bodies by identifying an enzyme that uses PQQ as a coenzyme in mammals and then by clarifying the oxidation-reduction reaction, with which PQQ is associated as a coenzyme in living bodies. The present invention provides a method of using pyrroloquinoline quinone as a coenzyme for 2-aminoadipate 6-semialdehyde dehydrogenase.

  本发明的目的是通过鉴定在哺乳动物中使用吡咯喹啉喹醌（PQQ）作为辅酶的酶，然后通过澄清PQQ作为辅酶与氧化还原反应相关联的方式，来澄清PQQ在生物体内的生化作用。本发明提供了一种利用吡咯喹啉喹醌作为2-氨基己二酸6-半醛脱氢酶的辅酶的方法。
• GLYCOCONJUGATES OF OPIATED SUBSTANCES
  申请人：ROLABO SL

  公开号：EP0816375A1

  公开（公告）日：1998-01-07

  They are comprised of a series of derivatives of carbohydrates of a family of biologically active opiated agents, which present in their structure at least one residue of carbohydrate per opiate molecule, linked directly to a hydroxyl group of the opiate or through a C-glycoside bond formed between two functions situated at each of the two constitutive parts of the glycoconjugate. Said derivatives contain more than one carbohydrate residue and/or more than one opiate molecule per carbohydrate residue. The acid salts and the compounds of said opiated glycoconjugates are also included in the disclosed compounds of said invention.

  它们由一系列衍生物组成，这些衍生物属于一类生物活性的阿片类化合物家族，其结构中至少有一个碳水化合物残基与每个阿片分子直接连接到阿片的一个羟基，或者通过位于糖脂联结物的两个构成部分的每个功能之间形成的C-糖苷键连接。这些衍生物包含一个碳水化合物残基和/或一个碳水化合物残基中的一个以上的阿片分子。所述阿片糖脂结合物的酸盐和化合物也包括在所述发明的所述化合物中。
• Method for the selection of genetically transformed cells and compounds for use in the method
  申请人：SANDOZ LTD.

  公开号：EP0530129A1

  公开（公告）日：1993-03-03

  A method for selecting from a population of cells genetically transformed cells into which a desired nucleotide sequence has been introduced, wherein in the transformed cells the desired nucleotide sequence or a co-introduced nucleotide sequence induces or increases a positive effect of a compound or nutrient supplied to the population of cells, thereby allowing the transformed cells to be identified or selected from non-transformed cells, e.g. for the preparation of genetically transformed plants not containing as a selection marker a non-native nucleotide sequence coding for toxin, antibiotic or herbicide resistance; as well as novel glucuronide compounds, including cytokinin glucuronide compounds, for use in the method.

  一种从经遗传转化的细胞群体中选择已引入所需核苷酸序列的细胞的方法，其中在转化的细胞中，所需核苷酸序列或共同引入的核苷酸序列诱导或增加化合物或营养物对细胞群体的正效应，从而允许识别或选择转化的细胞，例如用于制备不含有非天然核苷酸序列编码毒素、抗生素或除草剂抗性的选择标记的遗传转化植物；以及用于该方法的新型葡萄糖醛酸化合物，包括细胞分裂素葡萄糖醛酸化合物。
• Diagnostic/therapeutic agents
  申请人：Klaveness Jo

  公开号：US20050002865A1

  公开（公告）日：2005-01-06

  Targetable diagnostic and/or therapeutically active agents, e.g. ultrasound contrast agents, comprising a suspension in an aqueous carrier liquid of a reporter comprising gas-containing or gas-generating material, said agent being capable of forming at least two types of binding pairs with a target.

  可定位的诊断和/或治疗活性剂，例如超声对比剂，包括悬浮在水载体液中的报告物，该报告物包含含气体或生成气体的材料，该剂能够与目标形成至少两种结合对。
• COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN
  申请人：Toth Istvan

  公开号：US20100130581A1

  公开（公告）日：2010-05-27

  This invention relates to derivatives of an endomorphin, or of an endomorphin analog, comprising at least one moiety selected from a lipid moiety, a cyclitol moiety and a saccharide moiety.

  本发明涉及内啡肽的衍生物或内啡肽类似物的衍生物，其中至少包括一种取自脂质基团、环糖基团和糖基团的基团。

表征谱图